Most insights management processes are highly manual, not tech-enabled
A robust insights management strategy could enable companies to excel in a challenging environment. How should they tackle a transformation?
Life science trend tracker #6
In our ongoing series, we’re highlighting industry news and resources for deeper learning.
Orphan drug market: trends, insight, and more
How pharma companies are looking at the orphan drug market to identify opportunities for new treatments.
Artificial intelligence was a winner at the JP Morgan healthcare conference
AI-driven drug discovery continues to dominate industry conversations.
Life science trend tracker #5
Our first trend report of the year highlights industry news and shares resources for deeper learning.
Guide to real-world data vs real-world evidence
The two concepts are similar but distinct. Explore the differences and learn how they’re used.
3 ways pharma teams can create opportunities for commercial success
Optimizing operations in pre-clinical studies, trial design and execution, and expanded indications show promising potential.
Orphan drugs incentives and guidelines in 2023
A guide to applying for orphan drug status, including guidelines, incentives, and common challenges.
How real-world evidence can improve the pharma industry
What is RWE’s impact, and how can companies leverage it?
Value in virtual: new recommendations for KOL engagement
What are the new best practices for engaging KOLs and building successful relationships?